Target: CXCL9
Clone: MIG-2F5-5
Specificity: MIG-2F5-5 activity is directed against murine CXCL9 (monokine induced by gamma interferon, MIG).
Purification method: This monoclonal antibody was purified using Protein A
Antigen Distribution: CXCL9 is mainly secreted by macrophages, monocytes, endothelial cells, fibroblasts, and cancer cells in response to IFN-γ and is also expressed in intratumoral dendritic cells.
Immunogen: Mouse plasmacytoid dendritic cells
Concentration: ≥ 2.0 mg/ml
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: >98% by SDS-PAGE and HPLC
Endotoxin: ≤ 0.5 EU/mg as determined by the LAL method
Aggregation: Aggregation level ≤ 1%
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.